Our results show that AHRR (tumour suppressor) and SFRP2 (oncogene) are differentially expressed between primary and recurrent tumours both on the gene and the protein level and furthermore act as protein-based prognostic markers for HGSOC. The gene discussed is SFRP2; the disease is neoplasm.